Skip to main content

UK Sequencing Provider Buys Illumina Platforms

NEW YORK (GenomeWeb News) – Medical Solutions, a Nottingham, UK-based provider of DNA sequencing and genotyping services, this week announced that it has purchased Illumina’s next-generation sequencing instrument, the Genome Analyzer, and its BeadStation for whole-genome genotyping.
 
According to the firm, it is the first commercial service provider of those platforms in the UK.
 
“Customers have already expressed significant interest in applications run on the Genome Analyzer and BeadStation platforms, and it is our intention to develop strategic partnerships with these early adopters,” Tom Weaver, commercial director of Medical Solutions, said in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.